Bayer Crop Science, one of the three divisions of Germany-based life sciences enterprise Bayer, is bullish about the future of China's agricultural sector, citing the country's economic resilience, ...
Bayer’s New Business Model: Magnitude of Change “I’ve been with the company almost 18 years, and I’ve never been so excited or seen the team energized about an operating model like what we ...
Bayer’s network of Co.Lab life sciences incubators has expanded once again with the announcement of a new site in Shanghai, China, that will focus on oncology cell and gene therapies (CGT).
Bayer's stock has declined below €20, with Q3/24 results showing a 3.6% sales decrease and a 29.8% EBITDA drop, mainly due to currency effects. Crop Science sales fell 9.1% YoY, and ...
Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline as well as innovations around Artificial In ...